IQ Week Overview

October 11-14, 2022 // Washington, DC

The IQ Consortium invites you to attend a number of events we are hosting in the fall either in person or virtually. Join industry colleagues for a week of interactive discussions to explore new ideas and approaches in drug development. There are several opportunities to engage and reconnect! 

TUESDAY, OCTOBER 11

IQ CMC Leadership Group Meetings

start times vary - contact the IQ Secretariat lead
Faegre Drinker Biddle & Reath LLP, Washington, DC

  • Analytical Leadership Group (ALG) 1:00-5:00 PM ET
  • Biologics CMC Leadership Group (BIO LG) 12:00-5:00 PM ET
  • Drug Product Leadership Group (DPLG) 1:00-5:00 PM ET
  • Drug Substance Leadership Group (DSLG) 1:00-5:00 PM ET
  • Quality Leadership Group - GMP QA 1:00-3:00 PM ET
    IQ membership required to attend Leadership Group meetings

WEDNESDAY, OCTOBER 12

IQ CMC Summit 

9:00 AM – 5:15 PM ET 
Hamilton Hotel, Washington, DC

Building upon the Conventional and Collaborating on Novel and Emerging Areas in the Bio/Pharma/Medical Device Industries

The CMC Summit features plenary talks on contemporary topics and fosters an environment where members can explore collaborative topics, coordinate existing efforts, and launch new initiatives across Leadership Groups. This year, the CMC Summit features a holistic view of the IQ CMC Portfolio and examines various perspectives on novel and emerging modalities in pharmaceutical development. Attendees will have the opportunity to participate in interactive breakout sessions and explore potential areas of industry collaboration.

IQ Life Science Leadership Group Meetings

start times vary - contact the IQ Secretariat lead
Faegre Drinker Biddle & Reath LLP, Washington, DC

  • 3Rs Translational and Predictive Sciences Leadership Group (3Rs TPS LG) 1:00-5:00 PM ET
  • Clinical Pharmacology Leadership Group (CPLG) 8:00 AM - 4:30 PM
  • Quality Leadership Group - GLP QA (QLG - GLP QA) 1:00-3:30 PM ET
  • Quality Leadership Group - GLP QA & GMP QA (Joint) 3:30-5:00 PM ET
  • Translational and ADME Sciences Leadership Group (TALG) 1:30 - 5:30 PM 
  • Life Sciences Coordinating Committee (LSCC) 12:00 - 1:30 PM 

IQ membership required to attend Leadership Group meetings

 

Welcome Reception

6:00 PM – 7:30 PM ET 
Faegre Drinker Biddle & Reath LLP, Washington, DC

THURSDAY, OCTOBER 13

IQ Symposium

8:45 AM – 5:00 PM ET
National Press Club, Washington, DC

Emerging Trends in Pharmaceutical Innovation: Novel Modalities and Development Strategies

The past decade has seen a dramatic expansion of research and investment in nontraditional pharmaceutical modalities, including genetic medicine, next-generation vaccines, cell-based therapy, protein degraders, antibody-drug conjugates, and advanced peptides.

This wave of innovation is built on years of foundational research and driven in part by advances in genetics, protein and cell engineering, and nanotechnology. With these advances, the pharmaceutical industry has a tremendous opportunity to address unmet medical needs for genetic diseases. At the same time, these advancements come with new challenges in translating cutting-edge science to positive outcomes for patients.

FRIDAY, OCTOBER 14

IQ Board of Directors Meeting

9:00 AM - 2:00 PM ET
Faegre Drinker Biddle & Reath LLP, Washington, DC